Published in Lancet on November 10, 1984
Growth of Campylobacter pylori in liquid media. J Clin Microbiol (1987) 4.31
Campylobacter pyloridis--a new factor in peptic ulcer disease? Gut (1986) 3.26
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy. J Clin Pathol (1986) 2.38
Helicobacter pylori requires an acidic environment to survive in the presence of urea. Infect Immun (1995) 2.15
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut (1988) 1.98
Campylobacter like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation. Gut (1986) 1.88
Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial. Gut (1988) 1.61
Campylobacter pyloridis: what role in gastritis and peptic ulcer. Br Med J (Clin Res Ed) (1986) 1.36
Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistant to colonisation? Gut (1989) 1.17
Histological study of chronic gastritis from the United Arab Emirates using the Sydney system of classification. J Clin Pathol (1994) 1.16
Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Dig Dis Sci (2002) 0.88
Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol (2014) 0.83
Campylobacter-like organisms and Candida in peptic ulcers and similar lesions of the upper gastrointestinal tract: a study of 247 cases. J Clin Pathol (1988) 0.78
Inhibitory effects of Helicobacter pylori infection on murine autoimmune gastritis. Gut (2003) 0.76
Campylobacter pylori--a bacterial cause of peptic ulcer disease. Bull N Y Acad Med (1989) 0.75
Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet (1986) 10.07
The Vienna classification of gastrointestinal epithelial neoplasia. Gut (2000) 9.39
A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology (1997) 7.72
Screening dyspepsia by serology to Helicobacter pylori. Lancet (1991) 6.13
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Validation of a rapid whole blood test for diagnosing Helicobacter pylori infection. BMJ (1997) 5.80
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet (1999) 5.36
Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet (1999) 5.27
Early endoscopy of oesophagus, stomach, and duodenal bulb in patients with haematemesis and melaena. Br Med J (1973) 4.84
Gastric cancer: a curable disease in Britain. BMJ (1993) 4.24
Direct polymerase chain reaction test for detection of Helicobacter pylori in humans and animals. J Clin Microbiol (1991) 3.91
Gastric dysplasia: the Padova international classification. Am J Surg Pathol (2000) 3.66
Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK. Lancet (2000) 3.23
Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol (1987) 3.21
Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative. J Clin Pathol (1997) 2.98
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Identification of Helicobacter pylori DNA in the mouths and stomachs of patients with gastritis using PCR. J Clin Pathol (1993) 2.60
Observer variation in the histological grading of rectal carcinoma. J Clin Pathol (1983) 2.59
Bacterial adhesion and disease activity in Helicobacter associated chronic gastritis. Gut (1990) 2.58
Pancreatography in chronic pancreatitis: international definitions. Gut (1984) 2.37
Early gastric cancer in Europe. Gut (1997) 2.34
Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol (2000) 2.31
Chronic gastritis--a pathogenetic approach. J Pathol (1988) 2.31
Effect of duodenal ulcer surgery and enterogastric reflux on Campylobacter pyloridis. Lancet (1986) 2.27
An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis. Gut (1973) 2.21
Genetic abnormalities during transition from Helicobacter-pylori-associated gastritis to low-grade MALToma. Lancet (1995) 2.21
Effect of cimetidine on the gastric bacterial flora. Lancet (1980) 2.18
Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival. Br J Surg (1983) 2.17
Intestinal permeability assessed by excretion ratios of two molecules: results in coeliac disease. Br Med J (1978) 2.12
Early gastric cancer: 46 cases treated in one surgical department. Gut (1992) 2.10
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
PCR identification of Helicobacter pylori in faeces from gastritis patients. Lancet (1993) 2.00
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Randomised controlled trial of azathioprine withdrawal in ulcerative colitis. BMJ (1992) 1.94
Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94
Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer (1993) 1.93
Microsatellite instability in colorectal cancer: improved assessment using fluorescent polymerase chain reaction. Gastroenterology (1995) 1.92
Flat adenomas in the United Kingdom: are treatable cancers being missed? Endoscopy (1998) 1.92
Healing and recurrence of duodenal ulcer after treatment with tripotassium dicitrato bismuthate (TDB) tablets or cimetidine. Gut (1986) 1.83
Failure of colonoscopic surveillance in ulcerative colitis. Gut (1993) 1.82
Intestinal permeability and screening tests for coeliac disease. Gut (1980) 1.81
Acute polymyositis in an adult associated with Mycoplasma pneumoniae infection. Postgrad Med J (1990) 1.80
Endoscopic mucosal resection. Endoscopy (2001) 1.76
The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis (1988) 1.72
Ileal ecology after pouch-anal anastomosis or ileostomy. A study of mucosal morphology, fecal bacteriology, fecal volatile fatty acids, and their interrelationship. Gastroenterology (1989) 1.71
Disinfection of gastrointestinal fibre endoscopes. Lancet (1974) 1.71
Campylobacter-like organisms and heterotopic gastric mucosa in Meckel's diverticula. J Clin Pathol (1989) 1.71
p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer (1991) 1.70
MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis. A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol (1995) 1.70
Prognostic significance of DNA aneuploidy and cell proliferation in rectal adenocarcinomas. J Pathol (1987) 1.70
Controlled trial of intravenous hyperalimentation and total bowel rest as an adjunct to the routine therapy of acute colitis. Gastroenterology (1980) 1.69
Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation. J Clin Pathol (1990) 1.68
The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68
Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence? Dis Colon Rectum (1998) 1.66
Intestinal permeability in coeliac disease: the response to gluten withdrawal and single-dose gluten challenge. Gut (1982) 1.65
Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis (1991) 1.64
Effects of Helicobacter pylori eradication on the natural history of lymphocytic gastritis. Gut (1999) 1.62
Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology (1989) 1.61
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
Permeability of the small intestine to substances of different molecular weight. Gut (1970) 1.61
Factors influencing bowel function after ileal pouch-anal anastomosis. Br J Surg (1986) 1.60
Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen. Aliment Pharmacol Ther (1999) 1.59
Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut (1995) 1.58
Ascorbic acid in the human stomach. Gastroenterology (1989) 1.58
Silver-stained structures (AgNORs), their dependence on tissue fixation and absence of prognostic relevance in rectal adenocarcinoma. J Pathol (1989) 1.57
Disinfection in upper-digestive-tract endoscopy in Britain. Lancet (1981) 1.57
High grade dysplasia of the gastric mucosa: a marker for gastric carcinoma. Gut (1990) 1.56
Cellobiose/mannitol sugar test--a sensitive tubeless test for coeliac disease: results on 1010 unselected patients. Gut (1989) 1.55
Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg (1995) 1.54
The Leeds Dyspepsia Questionnaire: a valid tool for measuring the presence and severity of dyspepsia. Aliment Pharmacol Ther (1998) 1.52
Effects of tripotassium dicitrato bismuthate (TDB) tablets or cimetidine in the treatment of duodenal ulcer. Gut (1983) 1.52
Preservation of the spleen improves survival after radical surgery for gastric cancer. Gut (1995) 1.52